AbbVie Inc (NEOE:ABBV)
C$ 25.92 0.11 (0.43%) Market Cap: 457.28 Bil Enterprise Value: 549.05 Bil PE Ratio: 62.77 PB Ratio: 52.94 GF Score: 73/100

Q3 2024 AbbVie Inc Earnings Call Transcript

Oct 30, 2024 / 01:00PM GMT
Release Date Price: C$29.21 (+6.14%)
Operator

Good morning, and thank you for standing by. Welcome to the AbbVie third quarter 2024 earnings conference call. (Operator Instructions) Today's call is being recorded.

I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations.

Liz Shea
AbbVie Inc - Senior Vice President, Investor Relations

Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research and Development, Chief Scientific Officer; Scott Reents, Executive Vice President, Chief Financial Officer; and Carrie Strom, Senior Vice President, AbbVie and President Global Allergan Aesthetics.

Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on our current expectations. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot